{"html":"<p>Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We&#39;re seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.</p>\n<h4>Responsibilities</h4>\n<ul>\n<li><p>Create and critique rubrics that analyze commercial drugs and drug-development programs</p>\n</li>\n<li><p>Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers</p>\n</li>\n<li><p>Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions</p>\n</li>\n<li><p>Apply your assessment across the pilot&#39;s set of companies (~5–10)</p>\n</li>\n</ul>\n<h4>Requirements</h4>\n<ul>\n<li><p>US-based biotech / healthcare investment analyst with a specialist-fund background</p>\n</li>\n<li><p>Familiarity with biotech/pharma development programs</p>\n</li>\n<li><p>Able to assess a drug asset and the company behind it end-to-end</p>\n</li>\n<li><p>5+ years evaluating biotech/pharma companies or assets</p>\n</li>\n</ul>\n<h4>Engagement Details</h4>\n<ul>\n<li><p>Duration: Approximately 10–20 hours over a 1–2 week pilot</p>\n</li>\n<li><p>Remote — US-based</p>\n</li>\n</ul>\n<h4>Why Participate</h4>\n<ul>\n<li><p>Help improve expert AI evaluation of drugs and drug-development programs</p>\n</li>\n<li><p>Recurring engagement for strong contributors</p>\n</li>\n</ul>"}